We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMPD
3876
Empery Digital
EMPD
$79.8M
0
CSCI
3877
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$62K ﹤0.01%
1,676
-1,434
-46% -$51.6K
RKTO
3878
Rocket One Inc
RKTO
$17.9M
$61K ﹤0.01%
3,536
-3,148
-47% -$52.7K
IPW icon
3879
iPower
IPW
$958K
$61K ﹤0.01%
+151
New +$63.6K
SHPW
3880
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$61K ﹤0.01%
+2,650
New +$62.9K
APM
3881
DELISTED
Aptorum Group
APM
$60K ﹤0.01%
3,600
-4,596
-56% -$74K
SDEV
3882
Stablecoin Development Corp
SDEV
$31.2M
$60K ﹤0.01%
33
+12
+57% +$23K
FLUX icon
3883
Flux Power
FLUX
$11.2M
$59K ﹤0.01%
22,000
-23,807
-52% -$72.4K
JZXN icon
3884
Jiuzi Holdings
JZXN
$743K
$59K ﹤0.01%
5
+2
+67% +$29.2K
BEST
3885
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$59K ﹤0.01%
+4,535
New +$71.3K
INKT icon
3886
MiNK Therapeutics
INKT
$52.3M
$58K ﹤0.01%
2,576
-934
-27% -$28.1K
KPRX icon
3887
Kiora Pharmaceuticals
KPRX
$11.3M
$58K ﹤0.01%
+260
New +$68K
PL icon
3888
Planet Labs
PL
$7.3B
$58K ﹤0.01%
+11,500
New +$63.4K
UCL
3889
uCloudlink Group
UCL
$32.8M
$58K ﹤0.01%
32,800
+17,800
+119% +$33.2K
CIRC
3890
Circle8 Group
CIRC
$64.5M
$57K ﹤0.01%
1,043
-527
-34% -$30.6K
AKTX
3891
Akari Therapeutics
AKTX
$13.8M
$56K ﹤0.01%
58
-17
-23% -$17.9K
CRMD icon
3892
CorMedix
CRMD
$591M
$56K ﹤0.01%
+10,157
New +$46.5K
ZSAN
3893
DELISTED
Zosano Pharma Corporation
ZSAN
$56K ﹤0.01%
+7,115
New +$78.3K
ONCS
3894
DELISTED
OncoSec Medical Incorporated
ONCS
$56K ﹤0.01%
2,227
-9,108
-80% -$192K
ACHR icon
3895
Archer Aviation
ACHR
$3.54B
$55K ﹤0.01%
11,400
-147,335
-93% -$541K
NCTY
3896
The9 Ltd
NCTY
$68.1M
$55K ﹤0.01%
+1,838
New +$78.2K
SLNO
3897
DELISTED
Soleno Therapeutics
SLNO
$55K ﹤0.01%
16,547
+12,507
+310% +$64.8K
TENX icon
3898
Tenax Therapeutics
TENX
$363M
$55K ﹤0.01%
42
-8
-16% -$8.91K
GRCL
3899
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$55K ﹤0.01%
+23,600
New +$80.4K
STAB
3900
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$54K ﹤0.01%
171,918
-34,117
-17% -$36.5K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.